Multiple System Atrophy with Syndrome of Inappropriate Antidiuretic Hormone

Yu DD; Wang W; Tang W

Case Report

Austin J Neurol Disord Epilepsy. 2022; 8(1): 1050.

Multiple System Atrophy with Syndrome of Inappropriate Antidiuretic Hormone

Yu DD¹, Wang W² and Tang W¹*

¹Department of Neurology, Affiliated Hospital Xinhua Hospital, Dalian University, Dalian, China

²Department of Rehabilitation, Affiliated Hospital Zhongshan Hospital, Dalian University, Dalian, China

*Corresponding author: Tang W, Department of Neurology, Affiliated Hospital Xinhua Hospital, Dalian University, 156 Wansui St, Dalian, China

Received: September 30, 2022; Accepted: October 26, 2022; Published: November 02, 2022

Abstract

Multiple System Atrophy (MSA) is a rare neurodegenerative disease which mainly affects extrapyramidal system, cerebellum and autonomic nervous system as well as hypothalamus. Hypothalamic disturbances can lead to the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) and resultant hyponatremia. MSA with SIADH is rarely reported. We reported a 71-year-old woman was admitted to our hospital because of fever for two months. She was diagnosed with probable multiple system atrophy based on poorly L-Dopa responsive parkinsonism, urinary incontinence and orthostatic hypotension. Hyponatremia, and the urine sodium and osmolality increased indicating that she had SIADH at the same time. Hyponatremia was corrected after water restriction and sodium supplementation. In this report, we describe the clinical characteristics and treatment in regard to MSA with SIADH.

Keywords: Multiple System Atrophy; Syndrome of Inappropriate Antidiuretic Hormone; Hyponatremia; Antidiuretic Hormone

Introduction

Multiple System Atrophy (MSA) is a neurodegenerative disease with rapid progression and poor prognosis [1]. Pathologically, there is widespread presence of Oligodendroglial Cytoplasmic Inclusions (GCI) composed of a synuclein within the central nervous system [2]. According to the cardinal clinical motor symptoms [3], MSA can be divided into two subtypes: MSA parkinsonian type (MSA-P) and MSA cerebellar type (MSA-C). The main manifestation of MSA-P is rigidity and bradykinesia, while MSA-C is characterized by unstable gait and ataxia. Autonomic dysfunction and Non Motor Symptoms (NMS) can be seen in both two types, and may precede the typical motor symptoms [4]. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) [5] is a disorder defined by excess release of Antidiuretic Hormone (ADH), resulting in increased water retention. Common causes include pulmonary diseases, tumors, inflammation, central nervous system diseases, drugs or surgery [6]. Patients with MSA are at risk for SIADH. Research shows that MSA can affect the hypothalamus and its connecting fibers, cause hypersensitivity of antidiuretic hormone neurons in the hypothalamus, increase the secretion of antidiuretic hormone, and cause SIADH and hyponatremia [7].

Case Presentation

A 71-year-old woman was admitted to our hospital complaining of fever for two months. The result of COVID-19 nucleic acid test was negative. CT scan of chest showed bronchitis. Urinalysis showed white blood cell: 463.40 /μl and klebsiella pneumoniae was cultured in urine. Her temperature droped after anti infective treatment. Six years ago, she started manifesting with frequent urination, nocturia, constipation, unstable walking, bradykinesia and shouting at night. She was diagnosed as cerebellar atrophy four years ago and did not improve after symptomatic treatment. Walking instability gradually worsened and she had laryngeal stridor all day for two years. One year ago, she cannot hold the bowel, and had urinary incontinence. Two months ago, she was in bed with fever, dysphagia, barylalia and no sweat. On clinical examination, irregular breathing rhythm, laryngeal stridor, BP: 95/66mmHg (supine position), 114/53mmHg (sitting position). The breathing sound of both lungs was thick, and there were no scatte red dry and wet rales in both lungs. She was conscious but cannot cooperate with all neurological examination. Bilateral pulils were equal in size at 3.0 mm, which were sensitive to the light. The muscle strength was at grade and hypomyotonia. The muscle tension was weakened. Bilateral Babinski signs were positive. Cranial CT showed the obvious atrophy of brainstem and cerebellum, and T2-Weighted Image (T2WI) demonstrated the Hot-Cross-Bun Sign (HCB) in pons. MRI of pituitary was normal (Figure 1). According to the diagnostic criteria [8], she was diagnosed as probable multiple system atrophy.

Figure 1: CT (A) showing the volume of cerebellum and brainstem decreased significantly and the sulcus deepened. MRI (T1WI: B; T2WI: C) revealed the atrophy of cerebellum and the hot-cross-bun sign (HCB) on pons.


    

    

    Figure 1: CT (A) showing the volume of cerebellum and brainstem decreased significantly and the sulcus deepened. MRI (T1WI: B; T2WI: C) revealed the atrophy

of cerebellum and the hot-cross-bun sign (HCB) on pons.

Hematological examination showed normal serum sodium levels of 135.8 mmol/L on admission. However, serum sodium levels decreased to 121.0 mmol/L on the 7th day of the hospitalization. Plasma osmotic pressure was 259.11 mOsm/kg (280-310 mOsm/kg), urine osmolarity was 974 mOsm/kg (600-1000 mOsm/kg), and urine sodium was 460 mmol/24h (130-260mmol/24h). Thyroid, renal, and adrenal functions were normal. She was diagnosed as SIADH based on the diagnostic criteria of Bartter and Schwartz [9]. Her sodium was slowly corrected with hypertonic saline and she was also placed on fluid restriction, less than 2 L per day. Her serum sodium started to improve and became to narmal by the 29th hospitalization day (Table 1). According to the sensitive test of bacteria, she received the combination therapy of cefoperazone/sulbactam sodium and moxifloxacin, and her temperature returned to normal after 11 days of treatment (Table 1). At discharge, she could simply communicate with her family, but was still in bed.

Table 1: Changes of temperature and sodium during hospitalization.


    

    

    Table 1: Changes of temperature and sodium during hospitalization.

Discussion

Syndrome of Inappropriate Antidiuretic Hormone (SIADH) [5] is characterized by excessive release of antidiuretic hormone without kidney or endocrine disorder, which leads to obstruction of free water discharge. SIADH is the most common cause of clinical hyponatremia, and the causes of it are variable, such as tumor, pulmonary disease, central nervous system diseases, or drugs. Water restriction is the first-line recommended therapy in the current guidelines. Multiple System Atrophy (MSA) [1] is a fatal neurodegenerative disease which pathologically affects putamen, substantianigra, pons, inferior olivary nucleus, cerebellum and intermediolateral cell columns of spinal cord. MSA mainly manifests with motor symptoms and Non Motor Symptoms (NMS) [3]. Motor symptoms are more common in MSA-P, which should be differentiated from Parkinson’ Disease (PD). The incidence of NMS in the whole course of MSA is about 74%, which often occurs many years before motor symptoms, and may even be the only symptom, which seriously affects the prognosis [10]. NMS includes autonomic dysfunction, sleep disorders, cognitive impairment and psycho affective disorders [11]. Hyponatremia caused by MSA complicated with SIADH has been rarely reported (Table 2). Nagumo et al., [12] firstly reported the Shy-Drager syndrome with SIADH. Our patient had no evidence of tumor and PET-CT showed no abnormalities. No drugs related to SIADH were taken outside the hospital or during hospitalization, and no central nervous system diseases were observed. She had bronchitis on admission, but SIADH appeared on the 5th hospitalization day when the bronchitis had been better. So we speculated that pulmonary infection may be the predisposing factor for SIADH in MSA. The pathogenesis of MSA with SIADH remains unclear. There is no specific treatment for MSA, so the main treatment for MSA with SIADH is to remove the inducement and maintain the balance of water and sodium. Current treatments for SIADH include fluid restriction, intravenous salt solutions, oral sodium supplements, and oral vasopressin receptor antiseptics (tolvaptan) [5].

Download PDF

Citation: Yu DD, Wang W and Tang W. Multiple System Atrophy with Syndrome of Inappropriate Antidiuretic Hormone. Austin J Neurol Disord Epilepsy. 2022; 8(1): 1050.

Home

Journal Scope

Editorial Board

Instruction for Authors

Submit Your Article

Case	Age (year)/sex	Diagnosis	Serum Sodium (mmol/L)	Serum Osmolality (mOsm/kg H2O)	Urine osmolarity (mOsm/kg H2O)	Urine Sodium (mmol/L)	Concomitant disease
Nagumo K et al [12]	52/M	MSA-P	127	262	319	—	None
	61/F	MSA-C	99	205	474	—	Pneumonia
	52/M	MSA-P	127	262	319	—	—
	67/M	MSA-P	124	255	420	—	Cardiac pacemaker
SamukawaM et al [7]	52/M	MSA-C	120	246	381	—	Fever
	76/M	MSA-P	118	244	304	—	—
	62/F	MSA-C	118	254	—	—	Apnea
	58/F	MSA-P	116	—	722	—	Nephropyelitis
Xie MQ et al[13]	62/M	MSA-P	123	280	457	91	Pneumonia
	59/M	MSA-C	118	—	—	114	Pneumonia
	53/M	MSA-P	121	—	—	129	None
Su TT et al[14]	53/M	MSA-C	122	257.89	945.34	209	Pneumonia
Qiu JM et al[15]	58/M	MSA-P	113.1	243.2	—	307.2	Pneumonia

Multiple System Atrophy with Syndrome of Inappropriate Antidiuretic Hormone

Abstract

Introduction

Case Presentation

Discussion

References